Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Dianthus Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −1 vs. Q4 2022
- Shares held
- 29.7M
- +1.99M (+7.2%) vs. Q4 2022
- Total value
- $23.6M
- +$12.6M (+115.3%) vs. Q4 2022
- New holders
- 13
- 12 more added
- Sold out
- 14
- 10 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 6,050,000 | $4.81M | 0.72% | +6,050,000 | New |
| Lion Point Capital, LP | 4,558,466 | $3.62M | 2.00% | +4,558,466 | New |
| Atlas Venture Life Science Advisors, LLC | 3,791,698 | $3.01M | 0.41% | +315,162+9.1% | Added |
| Alphabet Inc. | 3,339,138 | $2.64M | 0.15% | 00.0% | Unchanged |
| Verition Fund Management LLC | 2,198,465 | $1.75M | 0.03% | +2,198,465 | New |
| Vanguard Group Inc | 1,968,421 | $1.56M | 0.00% | +4,183+0.2% | Added |
| Western Standard LLC | 1,439,374 | $1.14M | 1.16% | +1,439,374 | New |
| TCW Group Inc | 750,000 | $596.0K | 0.01% | +750,000 | New |
| Acadian Asset Management LLC | 614,213 | $486.0K | 0.00% | +493,415+408.5% | Added |
| Laurion Capital Management LP | 582,300 | $462.8K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 517,039 | $410.9K | 0.00% | +437,336+548.7% | Added |
| BlackRock Inc. | 465,969 | $370.3K | 0.00% | +2,933+0.6% | Added |
| Renaissance Technologies LLC | 393,400 | $313.0K | 0.00% | −194,522−33.1% | Reduced |
| Geode Capital Management, LLC | 357,690 | $284.3K | 0.00% | 00.0% | Unchanged |
| Harvard Management Co Inc | 332,610 | $264.3K | 0.03% | 00.0% | Unchanged |
| RBF Capital, LLC | 250,822 | $199.3K | 0.01% | −90,600−26.5% | Reduced |
| Bessemer Group Inc | 237,292 | $189.0K | 0.00% | 00.0% | Unchanged |
| Leonteq Securities AG | 200,000 | $158.9K | 0.01% | +20,000+11.1% | Added |
| Credit Suisse AG | 193,500 | $153.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 181,503 | $144.2K | 0.00% | +181,503 | New |
| Marshall Wace, LLP | 157,670 | $124.6K | 0.00% | +157,670 | New |
| Two Sigma Advisers, LP | 154,054 | $122.4K | 0.00% | −96,446−38.5% | Reduced |
| Bridgeway Capital Management, LLC | 152,700 | $121.4K | 0.00% | −59,500−28.0% | Reduced |
| Harbor Capital Advisors, Inc. | 152,138 | $120.9K | 0.03% | −8,774−5.5% | Reduced |
| State Street Corp | 139,207 | $110.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 97,335 | $77.4K | 0.00% | +10,724+12.4% | Added |
| Two Sigma Investments, LP | 91,373 | $72.6K | 0.00% | −94,752−50.9% | Reduced |
| Bank of New York Mellon Corp | 65,321 | $51.9K | 0.00% | +49,272+307.0% | Added |
| Cheyne Capital Management (UK) LLP | 47,170 | $37.5K | 0.12% | 00.0% | Unchanged |
| Corsair Capital Management, L.P. | 32,846 | $26.1K | 0.01% | +32,846 | New |
| Fiduciary Trust Co | 30,555 | $24.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28,222 | $22.4K | 0.00% | +21,188+301.2% | Added |
| Charles Schwab Investment Management Inc | 27,369 | $21.8K | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 13,800 | $11.0K | 0.00% | −14,200−50.7% | Reduced |
| Tower Research Capital LLC (TRC) | 13,189 | $10.0K | 0.00% | −25,619−66.0% | Reduced |
| Virtu Financial LLC | 10,724 | $9.00K | 0.00% | +10,724 | New |
| Sound View Wealth Advisors Group, LLC | 10,500 | $8.34K | 0.00% | +10,500 | New |
| Rathbone Brothers plc | 10,000 | $7.95K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 8,820 | $7.01K | 0.00% | +994+12.7% | Added |
| Belpointe Asset Management LLC | 5,500 | $4.37K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,372 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4,880 | $3.88K | 0.00% | −855−14.9% | Reduced |
| UBS Group AG | 2,797 | $2.22K | 0.00% | +2,797 | New |
| Simplex Trading, LLC | 3,241 | $2.00K | 0.00% | +3,241 | New |
| JPMorgan Chase & Co | 703 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 766 | $608 | 0.00% | +5+0.7% | Added |
| Umb Bank N A | 742 | $590 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 375 | $299 | 0.00% | +50+15.4% | Added |
| FMR LLC | 254 | $202 | 0.00% | +254 | New |
| Barclays PLC | 52 | $41 | 0.00% | −5,269−99.0% | Reduced |
| Institutional & Family Asset Management, LLC | 50 | $40 | 0.00% | 00.0% | Unchanged |
| Pension & Wealth Management Advisors, Inc. | 10 | $8 | 0.00% | 00.0% | Unchanged |
| TRV GP IV, LLC | 0 | $0 | 0.00% | −6,758,204−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −3,000,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −2,313,552−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −868,650−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −416,000−100.0% | Sold out |
| Bleichroeder LP | 0 | $0 | 0.00% | −346,631−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −152,984−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −129,395−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −75,806−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −38,059−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −34,090−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −12,237−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −737−100.0% | Sold out |
| Hellman Jordan Management Co Inc | – | – | – | – | Not filed |